Infigen Overview

  • Founded
  • 1997
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3

Infigen General Information

Description

Developer of nuclear transfer and genomic technologies for applications in human healthcare. The company focuses on improving drug production through cloning in the animal, agriculture and human health fields.

Contact Information

Website
www.infigen.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1825 Infinity Drive
  • DeForest, WI 53532
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Infigen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Infigen‘s full profile, request access.

Request a free trial

Infigen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Infigen‘s full profile, request access.

Request a free trial